Page last updated: 2024-10-28

ibuprofen and Dyslipidemias

ibuprofen has been researched along with Dyslipidemias in 1 studies

Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine

Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abu Zanat, FZ1
Qandil, AM1
Tashtoush, BM1

Other Studies

1 other study available for ibuprofen and Dyslipidemias

ArticleYear
A promising codrug of nicotinic acid and ibuprofen for managing dyslipidemia. I: synthesis and in vitro evaluation.
    Drug development and industrial pharmacy, 2011, Volume: 37, Issue:9

    Topics: Animals; Cyclooxygenase Inhibitors; Drug Combinations; Drug Design; Dyslipidemias; Half-Life; Humans

2011